Poly(allylamine)-tripolyphosphate Ionic Assemblies as Nanocarriers: Friend or Foe?

APUZZO, EUGENIA; AGAZZI, MAXIMILIANO; HERRERA, SANTIAGO E.; PICCO, AGUSTÍN; RIZZO, GASTÓN; CHAVERO, CAMILA; BIANCHI, DAIANA; SMALDINI, PAOLA; CORTEZ, MARÍA LORENA; MARMISOLLÉ, WALDEMAR A.; PADULA, GISEL; SEOANE, ANALÍA; ALOMAR, MARIA LIS; DENOFRIO, MARIA PAULA; DOCENA, GUILLERMO; AZZARONI, OMAR

ACS Applied Bio Materials

American Chemical Society

Lugar: Washington; Año: 2023

Designing effective drug nanocarriers that are easy to synthesize, robust, and nontoxic is a significant challenge in nanomedicine. Polyamine-multivalent molecule nanocomplexes are promising drug carriers due to their simple and all-aqueous manufacturing process. However, these systems can present issues of colloidal instability over time and cellular toxicity due to the cationic polymer. In this study, we finely modulate the formation parameters of poly(allylamine-tripolyphosphate) complexes to jointly optimize the robustness and safety. Polyallylamine was ionically assembled with tripolyphosphate anions to form liquid-like nanocomplexes with a size of around 200 nm and a zeta potential of −30 mV. We found that nanocomplexes exhibit tremendous long-term stability (9 months of storage) in colloidal dispersion and that they are suitable as protein-loading agents. Moreover, the formation of nanocomplexes induced by tripolyphosphate anions produces a switch-off in the toxicity of the system by altering the overall charge from positive to negative. In addition, we demonstrate that nanocomplexes can be internalized by bone-marrow-derived macrophage cells. Altogether, these nanocomplexes have attractive and promising properties as delivery nanoplatforms for potential therapies based on the immune system activation.